For help on how to get the results you want, see our search tips.
17 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Categories
Human Remove Human filter
Medicine type
Accelerated assessment Remove Accelerated assessment filter
Additional monitoring Remove Additional monitoring filter
Application type
Post-authorisation Remove Post-authorisation filter
-
List item
Summary of opinion: Translarna
ataluren, opinion date: 27/06/2019, Negative, Last updated: 18/10/2019 -
List item
Summary of opinion: Trelegy Ellipta
fluticasone furoate / umeclidinium / vilanterol, opinion date: 20/09/2018, Positive, Last updated: 21/09/2018 -
List item
Summary of opinion: Venclyxto
venetoclax, opinion date: 20/09/2018, Positive, Last updated: 21/09/2018 -
List item
Summary of opinion: Xarelto
rivaroxaban, opinion date: 26/07/2018, Positive, Last updated: 27/07/2018 -
List item
Summary of opinion: Rubraca
rucaparib, opinion date: 13/12/2018, Positive, Last updated: 14/12/2018 -
List item
Summary of opinion: Adcetris
brentuximab vedotin, opinion date: 13/12/2018, Positive, Last updated: 14/12/2018 -
List item
Summary of opinion: Hemlibra
emicizumab, opinion date: 31/01/2019, Positive, Last updated: 01/02/2019 -
List item
Summary of opinion: Tecentriq
atezolizumab, opinion date: 31/01/2019, Positive, Last updated: 01/02/2019 -
List item
Summary of opinion: Tecentriq
atezolizumab, opinion date: 27/06/2019, Positive, Last updated: 28/06/2019 -
List item
Summary of opinion: Tecentriq
atezolizumab, opinion date: 25/07/2019, Positive, Last updated: 26/07/2019 -
List item
Summary of opinion: Soliris
eculizumab, opinion date: 25/07/2019, Positive, Last updated: 26/07/2019 -
List item
Summary of opinion: Kalydeco
ivacaftor, opinion date: 17/10/2019, Positive, Last updated: 18/10/2019 -
List item
Summary of opinion: Revlimid
lenalidomide, opinion date: 14/11/2019, Positive, Last updated: 15/11/2019 -
List item
Summary of opinion: Darzalex
daratumumab, opinion date: 17/10/2019, Positive, Last updated: 18/10/2019 -
List item
Summary of opinion: Evotaz
atazanavir / cobicistat, opinion date: 17/10/2019, Positive, Last updated: 18/10/2019 -
List item
Summary of opinion: Dupixent
dupilumab, opinion date: 27/06/2019, Positive, Last updated: 28/06/2019 -
List item
Summary of opinion: Dupixent
dupilumab, opinion date: 19/09/2019, Positive, Last updated: 20/09/2019